Page last updated: 2024-08-23

paclitaxel and Foot Dermatoses

paclitaxel has been researched along with Foot Dermatoses in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, TY; Hong, RL; Hsieh, RK; Hwang, WS; Kao, WY; Lin, CH; Wang, CH1
Fujino, M; Maruhashi, K; Mitsudou, Y; Nakamura, T; Shimomatsuya, T; Shiraishi, S; Yonezawa, K1
Baker, WJ; Burris, HA; Keeling, JH; Von Hoff, D; Vukelja, SJ1
de Argila, D; Dominguez, JD; Iglesias, L1
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K1
Inbar, MJ; Merimsky, O1

Trials

2 trial(s) available for paclitaxel and Foot Dermatoses

ArticleYear
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fever; Foot Dermatoses; Hand Dermatoses; Humans; Liposomes; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Paresthesia; Polyethylene Glycols; Salvage Therapy; Treatment Outcome

2008
Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.
    Gynecologic oncology, 2000, Volume: 78, Issue:3 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythema; Fallopian Tube Neoplasms; Female; Foot Dermatoses; Hand Dermatoses; Humans; Liposomes; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Stomatitis; Stroke Volume

2000

Other Studies

4 other study(ies) available for paclitaxel and Foot Dermatoses

ArticleYear
[A case of severe hand-foot syndrome caused by capecitabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:7

    Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Paresthesia; Postoperative Period; Syndrome

2007
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere.
    Journal of the National Cancer Institute, 1993, Sep-01, Volume: 85, Issue:17

    Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Paclitaxel; Paresthesia; Pyridoxine; Taxoids

1993
Taxol-induced acral erythema.
    Dermatology (Basel, Switzerland), 1996, Volume: 192, Issue:4

    Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Paclitaxel

1996
Herceptin-taxol related hand and foot syndrome.
    The Israel Medical Association journal : IMAJ, 2000, Volume: 2, Issue:10

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Paclitaxel; Syndrome; Trastuzumab

2000